QSS
AXSM icon

Quantitative Systematic Strategies’s Axsome Therapeutics AXSM Stock Holding History

Quantitative Systematic Strategies’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,204
Closed -$264K – 590
2020
Q2 		$264K Sell
3,204
-490
-13% -$37.7K 0.05% 444
2020
Q1 		$217K Sell
3,694
-2,245
-38% -$183K 0.18% 199
2019
Q4 		$614K Sell
5,939
-6,513
-52% -$263K 0.09% 296
2019
Q3 		$252K Buy
12,452
+2,489
+25% +$64K 0.06% 365
2019
Q2 		$257K Buy
+9,963
New +$200K 0.05% 368

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Quantitative Systematic Strategies's AXSM Position: Q3 2020 in Review

Quantitative Systematic Strategies sold out of Axsome Therapeutics (AXSM) in Q3 2020, closing a stake of 3,204 shares — an estimated $264K sold.

Quantitative Systematic Strategies first reported a position in AXSM in Q2 2019 and held it in 5 quarters. The position peaked at $614K in Q4 2019. 174 funds tracked by Wall St. Rank hold AXSM as of Q3 2020.

  • Quantitative Systematic Strategies reported no remaining Axsome Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 3,204 Axsome Therapeutics shares in Q3 2020, an estimated $264K.
  • Quantitative Systematic Strategies first reported a position in Axsome Therapeutics in Q2 2019 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Axsome Therapeutics position peaked at $614K in Q4 2019.
  • 174 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2020, filed 9 Nov 2020.